Effective Alternatives for Ammonium Sulfate Treated Pharmaceutical Glass Vials

This whitepaper from The Medicine Maker and SCHOTT AG explores the evolving role of ready-to-use (RTU) technology in aseptic pharmaceutical manufacturing. It highlights the growing demand for flexibility in drug production due to trends such as smaller batch sizes, personalized medicine, and specialty drugs. The paper discusses the benefits of RTU systems, such as reduced setup times, lower capital investment, and enhanced product safety. It also emphasizes the importance of collaboration among suppliers, machine manufacturers, and pharmaceutical companies in developing innovative solutions like SCHOTT’s adaptiQ® nested vial system. Key insights from industry leaders underscore the need for partnership, patient-centric approaches, and a focus on quality to address the challenges of modern pharma manufacturing.

Register for the SCHOTT ID and get access to SCHOTT Pharma exclusive content:

SCHOTT ID is your central key to valuable information and features related to our products and applications. Whether you are an interested party, customer, or partner, you can benefit from simplified access to extended content, practical tools, and digital offerings alongside our range of products.